Author:
Edwards J. C. W.,Cambridge G.
Publisher
Oxford University Press (OUP)
Subject
Pharmacology (medical),Rheumatology
Cited by
70 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Latent and active tuberculosis development in patients with rheumatoid arthritis receiving biologic disease-modifying antirheumatic drugs: A single-center prospective study;PLOS ONE;2024-01-11
2. Design, synthesis and biological evaluation of novel pyrazolo-pyrimidin-amines as potent and selective BTK inhibitors;Bioorganic Chemistry;2023-01
3. An Open Label, Phase 1, Randomized, Seven-treatment, Seven-period, Crossover Study to Assess the Relative Bioavailability, pH Effect, Food Effect, and Dose Proportionality of CC-292, a Potent and Orally Available Bruton’s Tyrosine Kinase Inhibitor;European Journal of Drug Metabolism and Pharmacokinetics;2022-06-03
4. Application and prospect of targeting innate immune sensors in the treatment of autoimmune diseases;Cell & Bioscience;2022-05-26
5. An open‐label, phase 1, randomized, three treatments, three‐period, crossover, relative bioavailability study of CC‐292, a potent and orally available inhibitor of bruton tyrosine kinase;Journal of Clinical Pharmacy and Therapeutics;2022-03-20